What You Should Know:
– Enzee Health, formerly ZapIT! Medical is announcing it has secured $1.5M in seed financing, led by Rev1 Ventures with participation from Tamarind Hill, Harbor Street Ventures, M7 NEO, Redgrave Investments, Service Provider Capital and others.
– Enzee empowers hospital personnel to easily perform and track required quality testing within departments, eliminating the inefficiencies of paper record keeping, and making it easier for administrators to assess whether departments are compliant with quality standards and are inspection ready.
Innovating Electronic Systems to Quantify Quality in Healthcare
Enzee Health enables better quality healthcare through data. Enzee’s cloud-based platform helps measure compliance and quality across multiple modalities giving hospitals the power to provide better patient care. Its innovative technology allows hospital personnel to easily perform and track required quality testing within departments, eliminating the inefficiencies of paper record keeping and making it simple for administrators to assess whether departments are compliant with quality standards and inspection ready.
Enzee’s data management platform, ZapIT, automates quality control (QC) testing and maintains quality assessment (QA) data for all modalities in radiology and radiation oncology, in addition to managing records for all devices and processes of the QA program. Using Enzee’s ZapIT, hospitals are streamlining workflows and freeing up high-level clinical personnel to attend to other tasks. The app provides a first-class, comprehensive quality assurance practice management system for medical imaging, radiation oncology, and radiation safety. With this funding round, Enzee Health can expand into all departments to deliver comprehensive quality data into one platform for hospitals.
“We are excited to be partnering with Enzee Health and thrilled to have led its seed round – Bryon, Mike, and their team have deep expertise in managing quality assurance and compliance related to complex diagnostic equipment that is critical to delivering patient care,” said Ryan Helon, Executive Vice President, Investment Funds at Rev1 Ventures. “Enzee has a great understanding of the needs of healthcare providers now and into the future, and is well positioned to deliver value to its customers,” “We seek out companies that are built to scale and innovate – Enzee Health has the team and vision to do both.”
The company recently rebranded and launched a new website to reflect its broader approach of providing the same features that address the radiology and radiation oncology markets to supporting the entire hospital QA program, including connecting to existing compliance and test tracking apps, providing a holistic picture of a facility’s compliance and quality across personnel and departments.
“Enzee Health aligns well with our focus on supporting companies who are bringing innovative technology to healthcare providers that unlock efficiency, accuracy, and better patient experiences. Enzee is building what we believe is the start of an industry-changing approach to hospital compliance and QA,” said Mark Shary, Managing Partner at Tamarind Hill. “Bryon and the team have tapped into what is likely to become table stakes for how healthcare facilities manage compliance and quality assurance standards, and we’re excited to help them bring their capabilities to more markets as they grow.”
In order to keep pace with demand, the financing will support the additions of key hires to the Enzee Health team, including appointments in development, sales, and marketing.